Catharina Olsen

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Unlocking Health Data for Research: Legal, Technical, and Organisational Lessons from a Belgian Interdisciplinary Case Study.

Unlocking Health Data for Research: Legal, Technical, and Organisational Lessons from a Belgian Interdisciplinary Case Study.

Journal: Journal of healthcare informatics research

Published: August 13, 2025

ΔNP63 Defines an Exocrine-committed Subset of Murine Pancreatic Progenitor Cells.

ΔNP63 Defines an Exocrine-committed Subset of Murine Pancreatic Progenitor Cells.

Journal: Cellular and molecular gastroenterology and hepatology

Published: March 26, 2025

Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma.

Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma.

Journal: Blood advances

Published: March 12, 2025

Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders.

Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders.

Journal: European journal of medical genetics

Published: February 06, 2025

APCAD Part 2: A Novel Method for Detection of Meiotic Aneuploidy in Preimplantation Embryos.

APCAD Part 2: A Novel Method for Detection of Meiotic Aneuploidy in Preimplantation Embryos.

Journal: Genes

Published: December 11, 2024

RNA sequencing offers new diagnostic opportunities in neurodevelopmental disorders: A systematic review.

RNA sequencing offers new diagnostic opportunities in neurodevelopmental disorders: A systematic review.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: November 28, 2024

The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse.

The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 25, 2024

De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.

De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.

Journal: Cells

Published: July 04, 2024

Combining evolution and protein language models for an interpretable cancer driver mutation prediction with D2Deep.

Combining evolution and protein language models for an interpretable cancer driver mutation prediction with D2Deep.

Journal: Briefings in bioinformatics

Published: June 21, 2024

Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant Pairs.

Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant Pairs.

Journal: International journal of cancer

Published: May 10, 2024

A milder form of NSRP1-associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal.

A milder form of NSRP1-associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal.

Journal: American journal of medical genetics. Part A

Published: March 04, 2024

Comprehensive evaluation of the implementation of episignatures for diagnosis of neurodevelopmental disorders (NDDs).

Comprehensive evaluation of the implementation of episignatures for diagnosis of neurodevelopmental disorders (NDDs).

Journal: Human genetics

Published: July 28, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026